CBS News
@CBSNews·7M subscribers·153.5K videos
Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vials
Posted
August 28, 2024
Views
14,785
Likes
110
Comments
31
Engagement
0.95%
August 28, 2024
14,785
110
31
0.95%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
5:29Now PlayingEli Lilly is slashing prices for certain doses of its weight loss drug Zepbound, selling single-dose vials at much cheaper prices for people who pay out of pocket. Dr. Timothy Mackey, professor in the Global Health Program at the University of California, San Diego, joined CBS News to discuss the price cuts.
CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations that is available free to everyone with access to the internet and is the destination for breaking news, live events, original reporting and storytelling, and programs from CBS News and Stations' top anchors and correspondents working locally, nationally and around the globe. It is available on more than 30 platforms across mobile, desktop and connected TVs for free, as well as CBSNews.com and Paramount+ and live in 91 countries.
Subscribe to the CBS News YouTube channel
Watch CBS News 24/7
Download the CBS News app
Follow CBS News on Instagram
Like CBS News on Facebook
Follow CBS News on X
Subscribe to our newsletters
Try Paramount+ free
For video licensing inquiries, contact: licensing@veritone.com
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
